Mizuho Medy Co.,Ltd. (4595.T)
JPY 1482.0
(-0.47%)
JPY 1482.0
(-0.47%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.59 Billion JPY | 25.97% |
| 2022 | 1.26 Billion JPY | 0.17% |
| 2021 | 1.26 Billion JPY | -13.05% |
| 2020 | 1.45 Billion JPY | 27.43% |
| 2019 | 1.14 Billion JPY | -0.8% |
| 2018 | 1.15 Billion JPY | 46.52% |
| 2017 | 785.62 Million JPY | 5.18% |
| 2016 | 746.94 Million JPY | -13.99% |
| 2015 | 868.47 Million JPY | 46.41% |
| 2014 | 593.17 Million JPY | 3.88% |
| 2013 | 571 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 2.01 Billion JPY | 18.4% |
| 2024 Q1 | 1.7 Billion JPY | 6.54% |
| 2023 Q2 | 1.47 Billion JPY | -3.41% |
| 2023 Q3 | 1.5 Billion JPY | 2.32% |
| 2023 FY | 1.59 Billion JPY | 25.97% |
| 2023 Q4 | 1.59 Billion JPY | 6.12% |
| 2023 Q1 | 1.52 Billion JPY | 20.11% |
| 2022 Q3 | 1.16 Billion JPY | -15.85% |
| 2022 Q1 | 1.26 Billion JPY | -0.24% |
| 2022 FY | 1.26 Billion JPY | 0.17% |
| 2022 Q2 | 1.38 Billion JPY | 9.6% |
| 2022 Q4 | 1.26 Billion JPY | 8.87% |
| 2021 Q2 | 1.31 Billion JPY | -9.14% |
| 2021 Q4 | 1.26 Billion JPY | 0.89% |
| 2021 FY | 1.26 Billion JPY | -13.05% |
| 2021 Q1 | 1.44 Billion JPY | -0.66% |
| 2021 Q3 | 1.25 Billion JPY | -4.51% |
| 2020 Q1 | 1.32 Billion JPY | 16.09% |
| 2020 Q3 | 1.42 Billion JPY | -0.13% |
| 2020 FY | 1.45 Billion JPY | 27.43% |
| 2020 Q4 | 1.45 Billion JPY | 2.1% |
| 2020 Q2 | 1.42 Billion JPY | 7.64% |
| 2019 Q3 | 1.36 Billion JPY | 9.46% |
| 2019 FY | 1.14 Billion JPY | -0.8% |
| 2019 Q2 | 1.24 Billion JPY | -2.15% |
| 2019 Q1 | 1.27 Billion JPY | 10.39% |
| 2019 Q4 | 1.14 Billion JPY | -16.1% |
| 2018 Q4 | 1.15 Billion JPY | -1.01% |
| 2018 Q2 | 976.27 Million JPY | 35.17% |
| 2018 Q3 | 1.16 Billion JPY | 19.11% |
| 2018 Q1 | 722.23 Million JPY | -8.07% |
| 2018 FY | 1.15 Billion JPY | 46.52% |
| 2017 FY | 785.62 Million JPY | 5.18% |
| 2017 Q2 | 818.46 Million JPY | 17.66% |
| 2017 Q3 | 875.78 Million JPY | 7.0% |
| 2017 Q4 | 785.62 Million JPY | -10.29% |
| 2017 Q1 | 695.61 Million JPY | -6.87% |
| 2016 Q1 | 818.91 Million JPY | -5.71% |
| 2016 Q4 | 746.94 Million JPY | -25.72% |
| 2016 Q3 | 1 Billion JPY | 5.34% |
| 2016 Q2 | 954.68 Million JPY | 16.58% |
| 2016 FY | 746.94 Million JPY | -13.99% |
| 2015 Q4 | 868.47 Million JPY | 0.0% |
| 2015 FY | 868.47 Million JPY | 46.41% |
| 2014 FY | 593.17 Million JPY | 3.88% |
| 2013 FY | 571 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.71 Billion JPY | 76.23% |
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 99.868% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 98.616% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | 97.541% |
| Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | 20.41% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 95.918% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | 90.7% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 99.086% |
| Morishita Jintan Co., Ltd. | 3.18 Billion JPY | 49.871% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 92.46% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 94.727% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | 88.758% |
| Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | 85.109% |
| Tsumura & Co. | 117.61 Billion JPY | 98.643% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 93.928% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | 85.137% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 98.42% |
| Fuji Pharma Co., Ltd. | 19.37 Billion JPY | 91.758% |
| Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | 88.981% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | 97.014% |
| Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | 18.207% |
| Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 92.357% |
| SymBio Pharmaceuticals Limited | 232.03 Million JPY | -588.104% |
| MedRx Co., Ltd | 10 Million JPY | -15866.08% |
| Solasia Pharma K.K. | 122 Million JPY | -1208.695% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -25031.56% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | 92.174% |
| Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 98.403% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -3367.495% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | 98.171% |
| Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | 29.549% |